Javascript must be enabled to continue!
Medtronic, Inc. (A): The Garage Era
View through CrossRef
Useful in courses on entrepreneurship, this case describes the founding and start-up years (1949–62) of Medtronic, Inc., one of the world's leading medical-technology companies, specializing in implantable and interventional therapies. Focusing on one of the company's cofounders, Earl Bakken, the case examines entrepreneurial thinking and principles—“effectual reasoning.” See also "What Makes Entrepreneurs Entrepreneurial?" (UVA-ENT-0065).
Excerpt
UVA-ENT-0101
MEDTRONIC, INC. (A):
THE GARAGE ERA
In April 1949, Earl Bakken, a 25-year-old graduate student at the University of Minnesota, and his brother-in-law, Palmer Hermundslie, formed a partnership to service electric medical equipment. They set up shop in a garage and called their company Medtronic.
After a decade in business, Medtronic, Inc., had become a full-fledged medical-equipment manufacturer and a pioneer in implantable medical therapy. The external cardiac pacemaker that Bakken developed in 1957 was used not only by such prestigious American institutions as the Mayo Clinic in Rochester, Minnesota, and the National Institutes of Health in Bethesda, Maryland, but also by many outstanding medical facilities around the world. In the spring of 1961, when the few dozen Medtronic employees moved to a new 15,000-square-foot facility in Minneapolis, Minnesota, Medtronic's “garage era” was officially over.
But despite the hard-earned successes, all was not well at Medtronic. The small, undercapitalized, relatively inexperienced start-up had to face the rapid, expensive growth that followed the development of the external pacemaker and its implantable successor. While sales climbed from $ 180,000 to more than $ 500,000 between 1960 and 1962, Medtronic's losses rose like a tidal wave—from $ 16,000 to $ 144,000. The company was spending heavily on research and development, new facilities, expanded staff, and other business necessities, and its sales had not kept up. In an attempt to stay afloat, Medtronic was piling on debt, and it was getting dangerously close to insolvency.
. . .
Title: Medtronic, Inc. (A): The Garage Era
Description:
Useful in courses on entrepreneurship, this case describes the founding and start-up years (1949–62) of Medtronic, Inc.
, one of the world's leading medical-technology companies, specializing in implantable and interventional therapies.
Focusing on one of the company's cofounders, Earl Bakken, the case examines entrepreneurial thinking and principles—“effectual reasoning.
” See also "What Makes Entrepreneurs Entrepreneurial?" (UVA-ENT-0065).
Excerpt
UVA-ENT-0101
MEDTRONIC, INC.
(A):
THE GARAGE ERA
In April 1949, Earl Bakken, a 25-year-old graduate student at the University of Minnesota, and his brother-in-law, Palmer Hermundslie, formed a partnership to service electric medical equipment.
They set up shop in a garage and called their company Medtronic.
After a decade in business, Medtronic, Inc.
, had become a full-fledged medical-equipment manufacturer and a pioneer in implantable medical therapy.
The external cardiac pacemaker that Bakken developed in 1957 was used not only by such prestigious American institutions as the Mayo Clinic in Rochester, Minnesota, and the National Institutes of Health in Bethesda, Maryland, but also by many outstanding medical facilities around the world.
In the spring of 1961, when the few dozen Medtronic employees moved to a new 15,000-square-foot facility in Minneapolis, Minnesota, Medtronic's “garage era” was officially over.
But despite the hard-earned successes, all was not well at Medtronic.
The small, undercapitalized, relatively inexperienced start-up had to face the rapid, expensive growth that followed the development of the external pacemaker and its implantable successor.
While sales climbed from $ 180,000 to more than $ 500,000 between 1960 and 1962, Medtronic's losses rose like a tidal wave—from $ 16,000 to $ 144,000.
The company was spending heavily on research and development, new facilities, expanded staff, and other business necessities, and its sales had not kept up.
In an attempt to stay afloat, Medtronic was piling on debt, and it was getting dangerously close to insolvency.
.
.
.
Related Results
Design of double intelligent parking garage based on HuiYu technology
Design of double intelligent parking garage based on HuiYu technology
Abstract
In view of the ubiquitous parking problem in the city, a double-layer intelligent parking garage that saves space, is smart and labor-saving. On the basis o...
Assessment of Occupational Exposure to Lead Among Workers in City Bus Garage in Addis Ababa, Ethiopia: A Comparative Cross-Sectional Study
Assessment of Occupational Exposure to Lead Among Workers in City Bus Garage in Addis Ababa, Ethiopia: A Comparative Cross-Sectional Study
Abstract
Background: One of the most unusable chemical exposures that occurred in automotive garage areas was lead. Occupational exposure of garage workers to lead dust com...
Assessment of occupational exposure to lead among workers engaged in a city bus garage in Addis Ababa, Ethiopia: a comparative cross-sectional study
Assessment of occupational exposure to lead among workers engaged in a city bus garage in Addis Ababa, Ethiopia: a comparative cross-sectional study
AbstractBackgroundLead is one of the most nonessential toxic heavy metal agents found in automotive garages. The occupational exposure of garage workers to lead commonly poses acut...
Numerical Description of Jet and Duct Ventilation in Underground Garage after LPG Dispersion
Numerical Description of Jet and Duct Ventilation in Underground Garage after LPG Dispersion
Contamination of toxic and odorous gases emitted from stacks in buildings located in an urban environment are potential health hazards to citizens. A simulation using the computati...
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
Background: InRange has previously demonstrated that insulin glargine 300 U/mL (Gla-300) is non-inferior to insulin degludec 100 U/mL (IDeg-100) in terms of time in glucose range 7...
Biography pages of Juozas Albinas Lukša-Daumantas 1940–1941
Biography pages of Juozas Albinas Lukša-Daumantas 1940–1941
The article examines some pages of the life history of the famous post-war partisan Juozas Albinas Lukša Daumantas (10 August 1921 – 4 September 1951) from 1940 through 1941 that h...
Design of Intelligent Garage Control System Based on Internet of Things
Design of Intelligent Garage Control System Based on Internet of Things
Abstract
According to comb tooth mufti-layer parking equipment control problem, a control system based on Internet of things the garage is designed. The control syst...
Sustainability of Medtronic Surgical Devices
Sustainability of Medtronic Surgical Devices
Background
Medical devices used in surgery have the potential to impact the environment. While it is essential for medical devices to be accessible, of quality design & ...

